Status:
RECRUITING
Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Stroke
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study aims to analyze the use of non-invasive brain stimulation (tDCS) is beneficial for the treatment of post-stroke fatigue.
Detailed Description
A single-blind randomized clinical trial will be conducted. The intervention will consist of 8 20-minute tDCS sessions conducted over four weeks. The stimulation will be performed by applying the stim...
Eligibility Criteria
Inclusion
- First stroke within 45 (+-7) days of the ischemic or hemorrhagic episode.
- Ability to understand and execute simple instructions
- Over 18 years.
- Fatigue Scale of fatigue severity with a score greater than or equal to 24
Exclusion
- A score \> 2 on the modified Rankin Scale (mRS) before the stroke.
- Patients with decompensated cardiorespiratory and/or psychiatric pathology.
- Comorbidity causing disproportionate fatigue, such as long-term COVID.
- Patients who are cancer survivors or who are undergoing cancer treatment.
- Patients with a history of epilepsy or who are taking antiepileptic medication.
- Patents with major depression.
Key Trial Info
Start Date :
November 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 5 2026
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06149897
Start Date
November 10 2023
End Date
February 5 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clínic de Barcelona
Barcelona, Spain, Spain, 08036